Puma Biotech Drug Patent Portfolio
Puma Biotech's Family Patents
Clinical Trials
Recent Clinical Trials by Puma Biotech:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC) | Puma Biotechnology, Inc. | NA |
RECRUITING
(Sep 1, 2026)
| PHASE2 |
| A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer | Puma Biotechnology, Inc. | NA |
RECRUITING
(Jul 1, 2026)
| PHASE2 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List